Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported $1.33M in Stock for its fiscal quarter ending in December of 2022. Data for Agile Therapeutics | AGRX - Stock including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This dataset is about stocks per day and is filtered where the stock is AGRX, featuring 3 columns: closing price, date, and stock. The preview is ordered by date (descending).
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported $2.48M in Cost of Sales for its fiscal quarter ending in September of 2023. Data for Agile Therapeutics | AGRX - Cost Of Sales including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported $17.54M in Current Liabilities for its fiscal quarter ending in September of 2023. Data for Agile Therapeutics | AGRX - Current Liabilities including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported $-1.51 in EPS Earnings Per Share for its fiscal quarter ending in December of 2023. Data for Agile Therapeutics | AGRX - EPS Earnings Per Share including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported 0.4 in PE Price to Earnings for its fiscal quarter ending in June of 2023. Data for Agile Therapeutics | AGRX - PE Price to Earnings including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported $2.87M in Cash and Equivalent for its fiscal quarter ending in September of 2023. Data for Agile Therapeutics | AGRX - Cash And Equivalent including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported 2.51M in Outstanding Shares in March of 2024. Data for Agile Therapeutics | AGRX - Outstanding Shares including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported $4.18M in Gross Profit on Sales for its fiscal quarter ending in September of 2023. Data for Agile Therapeutics | AGRX - Gross Profit On Sales including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported $10.66M in Operating Expenses for its fiscal quarter ending in September of 2023. Data for Agile Therapeutics | AGRX - Operating Expenses including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported $3.61M in Sales Revenues for its fiscal quarter ending in December of 2023. Data for Agile Therapeutics | AGRX - Sales Revenues including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported $13K in Interest Income for its fiscal quarter ending in September of 2023. Data for Agile Therapeutics | AGRX - Interest Income including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported $0 in Ordinary Share Capital for its fiscal quarter ending in March of 2023. Data for Agile Therapeutics | AGRX - Ordinary Share Capital including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics reported $-4000000 in Operating Profit for its fiscal quarter ending in September of 2023. Data for Agile Therapeutics | AGRX - Operating Profit including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics 주식 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Mar 2025.Data for Agile Therapeutics | 주식 including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics Акции - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2025.Data for Agile Therapeutics | Акции including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics Stock - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.Data for Agile Therapeutics | Stock including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics Ação - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.Data for Agile Therapeutics | Ação including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics Aktie - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.Data for Agile Therapeutics | Aktie including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Agile Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.